Screener
GNOM vs KRMA
Global X Genomics & Biotechnology ETF vs Global X Conscious Companies ETF
Key differences
- KRMA costs 0.07% less per year.
- Over the last 3 years, KRMA has delivered higher annualized returns.
Side-by-side comparison
| GNOM | KRMA | |
|---|---|---|
| Annual cost (TER) | 0.50% | 0.43% |
| Fund size (AUM) | $51M | $116M |
| Since | 2019 | 2016 |
| Dividend yield | 1.38% | 2.46% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +53.6% | +26.4% |
| CAGR 3Y | -2.6% | +19.1% |
| CAGR 5Y | -10.5% | +10.7% |
| Sharpe 3Y | -0.06 | 1.01 |
| Volatility 1Y | 26.15% | 12.35% |
| Max drawdown | -75.00% | -36.16% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to GNOM and KRMA
Explore further